Cardiovascular Systems to Present at LEERINK Partners 5th Annual Global Healthcare Conference
February 03 2016 - 7:00AM
Business Wire
On Wednesday, February 10, 2016, Cardiovascular Systems’
(NASDAQ: CSII) Chief Financial Officer, Larry Betterley, will
present at the LEERINK Partners 5th Annual Global Healthcare
Conference at 2:40 p.m. Eastern Time.
You may access the live audio webcast and presentation materials
in the Investors section at: www.csi360.com. Presentation materials
also will be archived on CSI’s website.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted 510(k) clearance for the use of the Diamondback
Orbital Atherectomy System in peripheral arteries in August 2007.
In October 2013, the company received FDA approval for the use of
the Diamondback Orbital Atherectomy System in coronary arteries.
The Stealth 360® Peripheral Orbital Atherectomy System (OAS)
received CE Mark in October 2014. To date, over 235,000 of CSI’s
devices have been sold to leading institutions across the United
States. For more information, visit the company’s website at
www.csi360.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160203005141/en/
Cardiovascular Systems, Inc.Jack Nielsen,
651-202-4919j.nielsen@csi360.comorPadillaCRTMatt Sullivan,
612-455-1709matt.sullivan@padillacrt.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2023 to Jul 2024